methamphetamine has been researched along with Movement Disorders in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (55.56) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 5 (27.78) | 29.6817 |
| 2010's | 1 (5.56) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Barr, AM; Cho, LL; Gicas, KM; Honer, WG; Jones, AA; Kim, DD; Lang, DJ; Lee, LHN; Leonova, O; MacEwan, GW; Panenka, WJ; Procyshyn, RM; Stubbs, JL; Thornton, AE | 1 |
| Burns, L; Esterman, A; Faulkner, PL; Pearson-Dennett, V; Thewlis, D; Todd, G; Vogel, AP; White, JM; Wilcox, RA | 1 |
| Iida, A; Inoue, N; Kakiuchi, T; Kondo, Y; Muramatsu, S; Nakano, I; Nakayama, T; Okuno, T; Ono, F; Suzuki, Y; Takino, N; Terao, K; Tsukada, H | 1 |
| Jinnah, HA; Kasim, S | 1 |
| Endo, S; Ishibashi, S; Katsumata, N; Kuroiwa, T; Mizusawa, H; Yuan, SL | 1 |
| Fukuda, H; Kawakami, K; Morishita, R; Ogihara, T; Sata, M; Sato, N; Shimamura, M; Tomimatsu, T; Wakayama, K | 1 |
| Ellis, KL; Speed, J | 1 |
| Avison, MJ; Berger, JR; Maragos, WF; Nath, A; Schmitt, FA | 1 |
| Ellinwood, EH; kilbey, MM | 1 |
| Carlson, KR; Eibergen, RD | 1 |
| Kimura, M; Nishino, H; Ono, T; Shiosaka, S; Takahashi, J; Tohyama, M | 1 |
| Egawa, M; Hashimoto, N; Saito, K; Tobe, A | 1 |
| Jurna, I | 2 |
| Jurna, I; Lanzer, G | 1 |
| Bachmann, T; Jurna, I; Theres, C | 1 |
| Ellinwood, EH; Nelson, L; Sudilovsky, A | 1 |
| Bak, IJ; Hassler, R; Kim, JS; Kurokawa, M | 1 |
18 other study(ies) available for methamphetamine and Movement Disorders
| Article | Year |
|---|---|
Movement disorders associated with substance use in adults living in precarious housing or homelessness.
Topics: Adult; Cocaine; Dystonia; Female; Housing; Humans; Ill-Housed Persons; Methamphetamine; Movement Disorders; Quality of Life; Substance-Related Disorders | 2023 |
Prevalence of self-reported movement dysfunction among young adults with a history of ecstasy and methamphetamine use.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Brain; Cannabis; Central Nervous System Stimulants; Female; Hallucinogens; Humans; Logistic Models; Male; Methamphetamine; Movement Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Prevalence; Self Report; Young Adult | 2019 |
Multitracer assessment of dopamine function after transplantation of embryonic stem cell-derived neural stem cells in a primate model of Parkinson's disease.
Topics: Animals; Carbon Radioisotopes; Cells, Cultured; Cocaine; Disease Models, Animal; Dopamine; Dopamine Agents; Embryonic Stem Cells; Levodopa; Macaca fascicularis; Methamphetamine; Movement Disorders; Neurons; Parkinson Disease; Positron-Emission Tomography; Putamen; Raclopride; Tyrosine 3-Monooxygenase | 2009 |
Pharmacologic thresholds for self-injurious behavior in a genetic mouse model of Lesch-Nyhan disease.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Animals; Behavior, Animal; Caffeine; Calcium Channel Agonists; Central Nervous System Stimulants; Clonidine; Dystonia; Lesch-Nyhan Syndrome; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Movement Disorders; Pemoline; Piperazines; Self-Injurious Behavior | 2002 |
Extrapyramidal motor symptoms versus striatal infarction volume after focal ischemia in mongolian gerbils.
Topics: Animals; Basal Ganglia Diseases; Brain Infarction; Brain Ischemia; Corpus Striatum; Disease Models, Animal; Dopamine; Female; Functional Laterality; Gerbillinae; Hippocampus; Infarction, Middle Cerebral Artery; Male; Methamphetamine; Movement Disorders; Neurons; Rotation; Substantia Nigra | 2004 |
Quantitative measurement of neurological deficit after mild (30 min) transient middle cerebral artery occlusion in rats.
Topics: Animals; Behavioral Research; Brain Damage, Chronic; Brain Ischemia; Disease Models, Animal; Endpoint Determination; Infarction, Middle Cerebral Artery; Male; Methamphetamine; Motor Skills; Movement Disorders; Rats; Rats, Wistar; Rotation; Severity of Illness Index | 2007 |
Pharmacologic management of movement disorder after midbrain haemorrhage.
Topics: Activities of Daily Living; Adult; Brain Neoplasms; Carbidopa; Cavernous Sinus; Central Nervous System Stimulants; Cerebral Hemorrhage; Dopamine Agents; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Hemangioma, Cavernous; Humans; Levodopa; Male; Mesencephalon; Methamphetamine; Movement Disorders; Substance-Related Disorders | 1998 |
Acceleration of HIV dementia with methamphetamine and cocaine.
Topics: Adult; AIDS Dementia Complex; Amphetamine-Related Disorders; Antiretroviral Therapy, Highly Active; Blood-Brain Barrier; Brain; Cholinergic Antagonists; Cocaine-Related Disorders; Disease Progression; Humans; Levodopa; Magnetic Resonance Imaging; Male; Methamphetamine; Movement Disorders | 2001 |
Amphetamine stereotypy: the influence of environmental factors and prepotent behavioral patterns on its topography and development.
Topics: Animals; Arousal; Behavior; Behavior, Animal; Cats; Conditioning, Operant; Dogs; Environment; Haplorhini; Humans; Injections, Intravenous; Methamphetamine; Motor Activity; Movement Disorders; Rats; Social Behavior; Species Specificity; Stereotyped Behavior; Time Factors | 1975 |
Dyskinesias elicited by methamphetamine: susceptibility of former methadone-consuming monkeys.
Topics: Animals; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Haplorhini; Macaca mulatta; Male; Methadone; Methamphetamine; Movement Disorders; Receptors, Drug; Time Factors | 1975 |
Transplants in the peri- and intraventricular region grow better than those in the central parenchyma of the caudate.
Topics: Animals; Brain Diseases; Corpus Striatum; Dopamine; Hydroxydopamines; Mesencephalon; Methamphetamine; Movement Disorders; Neural Pathways; Oxidopamine; Rats; Substantia Nigra | 1986 |
[Effects of 4-(o-benzylphenoxy)-N-methylbutylamine hydrochloride (MCI-2016, bifemelane hydrochloride) on spontaneous motor activity under different experimental conditions].
Topics: Animals; Benzhydryl Compounds; Brain Injuries; gamma-Aminobutyric Acid; Hypoxia, Brain; Male; Methamphetamine; Mice; Motor Activity; Movement Disorders; Pantothenic Acid; Rats; Rats, Inbred Strains; Time Factors | 1985 |
Reserpine rigidity in the rat--a model for the analysis of antiparkinson drugs.
Topics: 1-Propanol; Animals; Biperiden; Cerebral Decortication; Electromyography; Methamphetamine; Models, Neurological; Motor Neurons; Movement Disorders; Parasympatholytics; Parkinson Disease; Piperidines; Rats; Reserpine | 1968 |
Depression by antiparkinson drugs of reserpine rigidity.
Topics: 1-Propanol; Animals; Biperiden; Cyclohexanes; Depression, Chemical; Electromyography; Methamphetamine; Movement Disorders; Parasympatholytics; Phenytoin; Piperidines; Rats; Reserpine; Sympathomimetics | 1968 |
Inhibition of the effect of reserpine on motor control by drugs which influence reserpine rigidity.
Topics: 1-Propanol; Animals; Atropine; Biperiden; Cyclohexanes; Cyclopentanes; Depression, Chemical; Dihydroxyphenylalanine; Methamphetamine; Motor Activity; Motor Neurons; Movement Disorders; Parasympathomimetics; Phenytoin; Piperidines; Rats; Reserpine; Spinal Cord; Sympathomimetics; Trihexyphenidyl | 1969 |
The effect of physostigmine and tetrabenazine on spinal motor control and its inhibition by drugs which influence reserpine rigidity.
Topics: 1-Propanol; Animals; Atropine; Biperiden; Dihydroxyphenylalanine; Electric Stimulation; Electromyography; Methamphetamine; Motor Neurons; Movement Disorders; Parasympatholytics; Phenytoin; Physostigmine; Piperidines; Rats; Reserpine; Spinal Cord; Spinal Nerves; Tetrabenazine; Trihexyphenidyl | 1969 |
Behavioral analysis of chronic amphetamine intoxication.
Topics: Animals; Attitude; Behavior, Animal; Cats; Disease Models, Animal; Electroencephalography; Humans; Methamphetamine; Motor Activity; Movement Disorders; Paranoid Disorders; Posture; Psychoses, Substance-Induced | 1972 |
Abnormal movements and rigidity induced by harmaline in relation to striatal acetylcholine, serotonin, and dopamine.
Topics: 5-Hydroxytryptophan; Acetylcholine; Alkaloids; Animals; Basal Ganglia; Brain Chemistry; Caudate Nucleus; Chlorine; Dopamine; Histocytochemistry; Indoles; Methamphetamine; Microscopy, Electron; Monoamine Oxidase Inhibitors; Movement Disorders; Rats; Serotonin; Synaptic Vesicles; Tremor | 1970 |